Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin.
Leishmaniasis is a serious global health problem affecting many people worldwide. While patients with leishmaniasis can be treated with several agents, drug toxicicty and the emergence of resistant strains render available treatments ineffective in the long run. Inhibitors of the mammalian target of...
Saved in:
Main Authors: | Fatemeh Khadir (Author), Christopher R Shaler (Author), Ahmad Oryan (Author), Patrick T Rudak (Author), Delfina M Mazzuca (Author), Tahereh Taheri (Author), Jimmy D Dikeakos (Author), S M Mansour Haeryfar (Author), Sima Rafati (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2018-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rapamycin activates mammalian microautophagy
by: Masahiro Sato, et al.
Published: (2019) -
Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
by: Won Seop Kim
Published: (2011) -
Retraction: Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
by: Won Seop Kim
Published: (2013) -
Renal toxicity with mammalian target of rapamycin inhibitors: A meta-analysis of randomized clinical trials
by: Ravi K. Paluri, et al.
Published: (2019) -
Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy
by: Helmschrott M, et al.
Published: (2017)